
ClearPoint Neuro CLPT
$ 9.53
0.21%
Annual report 2025
added 03-17-2026
ClearPoint Neuro Interest Expense 2011-2026 | CLPT
Interest expense is the amount of interest a company is obligated to pay to creditors for using debt financing (bank loans, bonds, leasing, etc.) during the reporting period.Includes:
- Interest on bank loans
- Interest on corporate bonds
- Interest on leases
- Interest on credit lines and overdrafts
High interest expenses indicate a high debt burden — the company may be vulnerable to rising rates or declining revenue.
Low interest expenses with high profits are a sign of financial stability.
Annual Interest Expense ClearPoint Neuro
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -146 K | -40 K | -29 K | -22 K | 973 K | 1.44 M | 955 K | 980 K | 873 K | 1.05 M | 1.26 M | 1.02 M | 500 K | 2.59 M | 2.5 M |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 2.59 M | -146 K | 928 K |
Quarterly Interest Expense ClearPoint Neuro
| 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -64 K | -52 K | 4 K | - | -11 K | 5 K | -26 K | - | -12 K | -2 K | -11 K | - | -25 K | -8 K | 11 K | - | 62 K | 240 K | 332 K | - | 201 K | 197 K | 842 K | - | 213 K | 259 K | 254 K | - | 247 K | 248 K | 247 K | - | 211 K | 213 K | 213 K | - | 240 K | 251 K | 345 K | - | 317 K | 312 K | 308 K | - | 289 K | 284 K | 151 K | - | 128 K | 130 K | 106 K | - | 85.8 K | 96 K | 2.33 M | - | 706 K | 598 K | 542 K |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 2.33 M | -64 K | 244 K |
Interest Expense of other stocks in the Medical devices industry
| Issuer | Interest Expense | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Medtronic PLC
MDT
|
402 M | $ 87.01 | -0.23 % | $ 112 B | ||
|
Axonics Modulation Technologies
AXNX
|
-2.43 M | - | - | $ 3.31 B | ||
|
Aziyo Biologics
AZYO
|
-2.76 M | - | 1.37 % | $ 20.5 M | ||
|
Acutus Medical
AFIB
|
5.66 M | - | -26.83 % | $ 2.62 M | ||
|
Allied Healthcare Products
AHPI
|
191 K | - | 3.58 % | $ 2.21 M | ||
|
BioSig Technologies
BSGM
|
23 K | - | 37.08 % | $ 85.7 M | ||
|
Conformis
CFMS
|
2.02 M | - | - | $ 16.4 M | ||
|
Cardiovascular Systems
CSII
|
1.63 M | - | 0.15 % | $ 844 M | ||
|
Apollo Endosurgery
APEN
|
4.67 M | - | - | $ 475 M | ||
|
LENSAR
LNSR
|
660 K | $ 5.6 | -7.74 % | $ 64.5 M | ||
|
Avinger
AVGR
|
1.72 M | - | -20.74 % | $ 369 K | ||
|
AxoGen
AXGN
|
167 K | $ 32.7 | 2.98 % | $ 1.51 B | ||
|
CONMED Corporation
CNMD
|
31.1 M | $ 37.03 | 1.09 % | $ 1.15 B | ||
|
Orthofix Medical
OFIX
|
8.11 M | $ 11.86 | -0.13 % | $ 470 M | ||
|
Electromed
ELMD
|
78 K | $ 24.73 | 0.98 % | $ 209 M | ||
|
Neovasc
NVCN
|
133 K | - | - | $ 111 M | ||
|
Aethlon Medical
AEMD
|
10.1 K | $ 2.16 | -6.09 % | $ 3.37 M | ||
|
Penumbra
PEN
|
893 K | $ 335.02 | -0.17 % | $ 13 B | ||
|
BIOLASE
BIOL
|
-1 K | - | -13.19 % | $ 166 K | ||
|
AdaptHealth Corp.
AHCO
|
-274 K | $ 11.65 | 12.34 % | $ 1.57 B | ||
|
Myomo
MYO
|
-668 K | $ 0.69 | -2.28 % | $ 28.9 M | ||
|
Insulet Corporation
PODD
|
14.3 M | $ 226.85 | -0.1 % | $ 16 B | ||
|
Invacare Corporation
IVC
|
28.5 M | - | - | $ 24.7 M | ||
|
Profound Medical Corp.
PROF
|
146 K | $ 5.14 | -4.76 % | $ 180 M | ||
|
EDAP TMS S.A.
EDAP
|
232 K | $ 3.92 | 4.96 % | $ 146 M | ||
|
OrthoPediatrics Corp.
KIDS
|
6.05 M | $ 16.0 | -2.88 % | $ 375 M | ||
|
Outset Medical
OM
|
14 M | $ 3.55 | -1.94 % | $ 54 K | ||
|
Quanterix Corporation
QTRX
|
157 K | $ 3.76 | -4.57 % | $ 160 M | ||
|
Inspire Medical Systems
INSP
|
-2.66 M | $ 52.18 | -0.06 % | $ 1.53 B | ||
|
Pulmonx Corporation
LUNG
|
790 K | $ 1.33 | -4.32 % | $ 54.1 M | ||
|
Cutera
CUTR
|
-244 K | - | -10.19 % | $ 1.99 M | ||
|
Dynatronics Corporation
DYNT
|
410 K | - | 14.99 % | $ 929 K | ||
|
Sintx Technologies
SINT
|
31 K | $ 2.57 | 0.78 % | $ 7.13 M | ||
|
InspireMD
NSPR
|
200 K | $ 1.79 | 2.87 % | $ 115 M | ||
|
Eargo
EAR
|
549 K | - | - | $ 10.2 M | ||
|
NuVasive
NUVA
|
-21.4 M | - | - | $ 2.07 B | ||
|
Second Sight Medical Products
EYES
|
1.19 M | - | -0.97 % | $ 54.4 M |